Geron halts Phase 3 imetelstat study in myelofibrosis
Geron said it halted its Phase 3 study of imetelstat in myelofibrosis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.